Cholesterol Drugs May Help Some Stroke Survivors Avoid Second Stroke, Study Finds

Scientists: Premature Births Account for More Than 30 Percent of Infant Deaths

HealthDay - THURSDAY, Oct. 5 (HealthDay News) -- The sleep medication ramelteon (brand name Rozerem), recently approved in the United States to treat insomnia, does not appear to have potential for substance abuse or for motor or cognitive impairment, acc...